| Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments LW Dunne, Z Huang, W Meng, X Fan, N Zhang, Q Zhang, Z An Biomaterials 35 (18), 4940-4949, 2014 | 183 | 2014 |
| Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine DC Freed, Q Tang, A Tang, F Li, X He, Z Huang, W Meng, L Xia, ... Proceedings of the National Academy of Sciences 110 (51), E4997-E5005, 2013 | 151 | 2013 |
| Visualizing influenza virus infection in living mice W Pan, Z Dong, F Li, W Meng, L Feng, X Niu, C Li, Q Luo, Z Li, C Sun, ... Nature communications 4 (1), 2369, 2013 | 124 | 2013 |
| Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein G Wei, W Meng, H Guo, W Pan, J Liu, T Peng, L Chen, CY Chen PloS one 6 (12), e28309, 2011 | 72 | 2011 |
| Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation Y Shi, X Fan, W Meng, H Deng, N Zhang, Z An Breast Cancer Research 16, 1-11, 2014 | 57 | 2014 |
| Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection L Xia, A Tang, W Meng, DC Freed, L He, D Wang, F Li, L Li, W Xiong, ... Oncotarget 8 (43), 73654, 2017 | 33 | 2017 |
| Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes L Li, W Meng, M Horton, DR DiStefano, EA Thoryk, JM Pfaff, Q Wang, ... PLoS pathogens 15 (6), e1007716, 2019 | 29 | 2019 |
| Rapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseases W Meng, W Pan, AJX Zhang, Z Li, G Wei, L Feng, Z Dong, C Li, X Hu, ... PLoS One 8 (6), e66276, 2013 | 29 | 2013 |
| Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells W Meng, L Li, W Xiong, X Fan, H Deng, AJ Bett, Z Chen, A Tang, KS Cox, ... MAbs 7 (4), 707-718, 2015 | 26 | 2015 |
| Targeting human-cytomegalovirus-infected cells by redirecting T cells using an anti-CD3/anti-glycoprotein B bispecific antibody W Meng, A Tang, X Ye, X Gui, L Li, X Fan, RD Schultz, DC Freed, S Ha, ... Antimicrobial Agents and Chemotherapy 62 (1), 10.1128/aac. 01719-17, 2018 | 19 | 2018 |
| Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34 W Pan, Z Dong, W Meng, W Zhang, T Li, C Li, B Zhang, L Chen Human Vaccines & Immunotherapeutics 8 (2), 252-259, 2012 | 16 | 2012 |
| Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice X Hu, W Meng, Z Dong, W Pan, C Sun, L Chen Virus research 155 (1), 156-162, 2011 | 7 | 2011 |
| Anti-IL1RAP/CD3 bispecific antibody (BsAb) is a promising novel and effective therapy for acute myeloid leukemia (AML) W Meng, M Del Real, G Wei, R Hernandez, E Marcucci, A Lin, T Mcdonald, ... Blood 130, 1361, 2017 | 5 | 2017 |
| Active evolution of memory B-cells specific to viral gH/gL/pUL128/130/131 pentameric complex in healthy subjects with silent human cytomegalovirus infection. Oncotarget 8 … L Xia, A Tang, W Meng, DC Freed, L He, D Wang, F Li, L Li, W Xiong, ... | 5 | 2017 |
| Anti-IL1RAP antibodies M Weixu, G Marcucci US Patent 11,370,842, 2022 | 1 | 2022 |
| PNCŊ27 Targeting Plasma Membrane HDM2: A Potentially Novel Therapeutic Approach for Acute Myeloid Leukemia (AML) H Wang, B Zhang, D Zhao, E Troadec, W Meng, A Lin, AS Stein, ... Blood 130, 2518, 2017 | 1 | 2017 |
| Anti-il1rap antibodies M Weixu, G Marcucci US Patent App. 17/809,489, 2023 | | 2023 |
| Il1rap antibodies B Zhang, M Weixu, G Marcucci US Patent App. 17/634,895, 2022 | | 2022 |
| Modulation of wnt signaling in gastrointestinal disorders WM Yang Li, Chenggang Lu, Helen Baribault,, Wen-Chen Yeh, Liqin Xie, I-Chieh ... WO Patent WO/2020/185,960, 2020 | | 2020 |
| Downregulation of Mir-142 Promotes Leukemia Growth in Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): A Possible Novel Therapeutic Target? H Wang, B Zhang, WL Wang, D Zhao, L Li, H Wu, W Meng, T McDonald, ... Blood 132, 1338, 2018 | | 2018 |
Zhiqiang AnProfessor of Molecular Medicine, University of Texas Health Science Center at HoustonVerified email at uth.tmc.edu
